r the SEC. Given these uncertainties, assumptions and risk
factors, readers are cautioned not to place undue reliance on such
forward-looking statements. We disclaim any obligation to update any such
factors or to publicly announce the result of any revisions to any of the
forward-looking statements contained in this press release to reflect
future results, events or developments.
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical
and medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases
or complications associated with medical device implants, surgical
interventions and acute injury. To find out more about Angiotech (NASDAQ:
ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.
(1) Maki, DG et al. Mayo Clin Proc 2006;81:1159-1171.
(2) Orsi, GB et al. Infect Control Hosp Epidemiol 2002;23:190-197.
(3) Blot, SI et al. Clin Infect Dis 2005;41:1591-1598.
(4) O'Grady, NP et al. MMWR Recomm Rep 2002;51:1-29.
(5) Renaud, B et al. Am J Respir Crit Care Med 2001;163:1584-1590
(6) Mermel, LA. Prevention of intravascular catheter-related infections.
Ann Intern Med. 2000; 132:391-402.
CONTACT: Deirdre Neary, Angiotech Pharmaceuticals, Inc., (604)
Page: 1 2 3 4 5 6 7 Related biology technology :1
|SOURCE Angiotech Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved
. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients2
. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain3
. Kline Study: Better Brushing Habits Boost European Oral Care Sales4
. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia5
. NASA study will help stop stowaways to Mars6
. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome7
. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer8
. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 2019
. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes10
. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy11
. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting